Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Menovo Tiankang Pharmaceutical
Ningbo, Zhejiang, Chinamenovopharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company primarily produces solid oral drug formulations, mainly for the Chinese and European markets, and has demonstrated successful bioequivalence studies for drugs such as bilastine tablets in healthy volunteers[1][6].
- Therapeutic areas
- ImmunologyDermatology
- Modalities
- Small moleculeSolid oral dosage forms (tablets, capsules)
- Industry
- Biotech
Beyond the preview
Go deeper on Ningbo Menovo Tiankang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningbo Menovo Tiankang Pharmaceutical.